Drug intelligence / Profile preview

Sinolpan

Development stage
Unknown
Lead developer
Engelhard Arzneimittel
Modality
Small Molecules
Administration
Oral
01

Overview

Sinolpan is an over‑the‑counter, plant‑derived respiratory medicine based on **cineole**, a monoterpene oxide purified from eucalyptus oil, formulated as gastro‑resistant soft capsules for systemic delivery in the intestine.[1][3][4][5][7][9] It is marketed by Engelhard Arzneimittel for the symptomatic treatment of bronchitis, colds, and acute or chronic inflammatory diseases of the upper and lower respiratory tract such as rhinosinusitis and sinusitis, where it acts as an expectorant and anti‑inflammatory agent that liquefies and mobilizes viscous mucus, facilitates mucociliary clearance, decongests the nasal passages, and reduces pressure sensations in the head.[1][3][5][7][9] By modulating mucus production and exerting anti‑inflammatory effects on the airway mucosa, Sinolpan improves breathing comfort and quality of life in adults and children when used as adjunctive therapy in respiratory infections.[1][3][5][6][8][9]

Brand names
SinolpanSinolpan forte
Other names
cineole1,8-cineoleeucalyptol
02

Targets

TRPA1 (Transient receptor potential cation channel subfamily A member 1)

Beyond the preview

Go deeper on Sinolpan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sinolpan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call